0
Your cart

Your cart is empty

Books > Medicine > Nursing & ancillary services

Buy Now

Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk (Paperback) Loot Price: R3,114
Discovery Miles 31 140
Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk (Paperback): Michael J Klepper, Barton Cobert

Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk (Paperback)

Michael J Klepper, Barton Cobert

 (sign in to rate)
Loot Price R3,114 Discovery Miles 31 140 | Repayment Terms: R292 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk was selected for The First Clinical Research Bookshelf - Essential reading for clinical research professionals by the Journal of Clinical Research Best Practices. Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk provides drug safety/pharmacovogilance professionals, pharmaceutical and clinical research scientists, statisticians, programmers, medical writers, and technicians with an accessible, practical framework for the analysis, summary and interpretation of drug safety data. The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for pre- and post-marketing risk assessment. With decades of pharmaceutical research and drug safety expertise, authors Dr. Klepper and Dr. Cobert discuss how quality planning, safety training, and data standardization result in significant cost, time, and resource savings. Through illustrative, step-by-step instruction, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is the definitive guide to drug safety data analysis and reporting. Key features include: * Step-by-step instruction on how to analyze, summarize and interpret safety data for mandatory governmental safety reports * Pragmatic tips...and mistakes to avoid * Simple explanations of what safety data are collected, and what the data mean * Practical approaches to determining a drug effect and understanding its clinical significance * Guidance for determining risk throughout the lifecycle of a drug, biologic or nutraceutical * Examples of user-friendly data displays that enhance safety signal identification * Ways to improve data quality and reduce the time, resources and costs involved in mandatory safety reporting * Relevant material for the required training of drug safety/pharmacovigilance professionals * SPECIAL FEATURE: Actual examples of an Integrated Analysis of Safety (IAS) -used in the preparation of the Integrated Summary of Safety (ISS) and the Summary of Clinical Safety (SCS) reports -, and the Periodic Safety Update Report (PSUR)

General

Imprint: Jones And Bartlett Publishers, Inc
Country of origin: United States
Release date: September 2010
First published: 2011
Authors: Michael J Klepper • Barton Cobert
Dimensions: 275 x 217 x 18mm (L x W x T)
Format: Paperback
Pages: 316
ISBN-13: 978-0-7637-6912-3
Categories: Books > Medicine > Nursing & ancillary services > General
LSN: 0-7637-6912-6
Barcode: 9780763769123

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners